2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$343.84-$1.97 (-0.57%)
Price as of Nov 11, 2026 7:30 PM EST- $16.6BMarket Cap
- 99.31%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$343.84-$1.97 (-0.57%)
CRL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $345.80 | ||
Change | -$7.54 (-2.13%) | ||
Open | $350.44 | ||
High | $352.50 | ||
Low | $342.39 | ||
Previous Close | $353.34 | ||
Volume | 822,079 | ||
30-Day Average Volume | 1,241,538 | ||
1-Week Change | -1.73% | ||
1-Month Change | 14.58% | ||
1-Year Change | 99.31% | ||
3-Year Change | 101.06% | ||
5-Year Change | -10.78% | ||
Fundamentals | |||
Shares Outstanding | 47.9M | ||
Total Assets | $7.5B | ||
Market Cap | $16.6B | ||
Enterprise Value | $18.8B | ||
Period: QTR TTM FY | |||
Revenue | $780.3M | ||
Net Income | $333.1M | ||
Free Cash Flow | $207.3M | ||
EBIT | $169.3M | ||
EBITDA | $241.5M | ||
Net Working Capital | $445.8M | ||
EPS | $6.86 | ||
Enterprise Value/EBITDA | 78 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 5 | ||
P/E | 50 | ||
PEG | 0 | ||
Price/Free Cash Flow | 80 | ||
Price/Operating Cash Flow | 65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue